These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 2577327)

  • 21. A monoclonal antibody detecting unusual Thy-1 determinants.
    Auchincloss H; Ozato K; Sachs DH
    J Immunol; 1982 Apr; 128(4):1584-9. PubMed ID: 6174608
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antibodies in the treatment of lymphoma.
    Leonard JP
    Clin Adv Hematol Oncol; 2004 Apr; 2(4):210-1. PubMed ID: 16163182
    [No Abstract]   [Full Text] [Related]  

  • 23. Phenotypic and functional properties of murine thymocytes. II. Quantitation of host- and donor-derived cytolytic T lymphocyte precursors in regenerating radiation bone marrow chimeras.
    Ceredig R; MacDonald HR
    J Immunol; 1982 Feb; 128(2):614-20. PubMed ID: 6119345
    [No Abstract]   [Full Text] [Related]  

  • 24. Allogeneic bone marrow transplantation in newborn mice treated pre- and post-natally with anti-THY 1.2 monoclonal antibody.
    Culver KW; Smith WL; Cowan MJ
    Transplant Proc; 1989 Feb; 21(1 Pt 3):2939. PubMed ID: 2565065
    [No Abstract]   [Full Text] [Related]  

  • 25. Purification and characterization of Rana pipiens brain Thy-1 glycoprotein.
    Mansour MH; Cooper EL
    J Immunol; 1984 May; 132(5):2515-23. PubMed ID: 6201547
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An allogeneic immunosuppressive monoclonal anti-T cell antibody can elicit neutralizing anti-antibodies in mice.
    Kremmer E; Mysliwietz J; Lederer R; Thierfelder S
    Transplant Proc; 1993 Feb; 25(1 Pt 1):842-3. PubMed ID: 8094918
    [No Abstract]   [Full Text] [Related]  

  • 27. A novel anti-Thy-1 (CD90) monoclonal antibody induces apoptosis in mouse malignant T-lymphoma cells in spite of inducing bcl-2 expression.
    Fujita N; Kato Y; Naito M; Tsuruo T
    Int J Cancer; 1996 May; 66(4):544-50. PubMed ID: 8635872
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Murine cardiac allograft survival following treatment of recipients with monoclonal anti-L3T4 or Ly-2 antibodies.
    Mottram PL; Wheelahan J; McKenzie IF; Clunie GJ
    Transplant Proc; 1987 Apr; 19(2):2898-901. PubMed ID: 3105127
    [No Abstract]   [Full Text] [Related]  

  • 29. Prolongation of murine cardiac allografts following treatment of graft recipients with monoclonal anti-L3T4 and Ly-2 antibodies.
    Mottram PL; Wheelahan J; Mirisklavos A; Clunie GJ; McKenzie IF
    Transplant Proc; 1987 Feb; 19(1 Pt 1):582-5. PubMed ID: 3103281
    [No Abstract]   [Full Text] [Related]  

  • 30. Serologic relatedness between Thy-1.2 and actin revealed by monoclonal antibody.
    Dales S; Fujinami RS; Oldstone MB
    J Immunol; 1983 Sep; 131(3):1332-8. PubMed ID: 6136544
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Thy-1 antigen expression by murine high-proliferative capacity hematopoietic progenitor cells. I. Relation between sensitivity to depletion by Thy-1 antibody and stem cell generation potential.
    Boswell HS; Wade PM; Quesenberry PJ
    J Immunol; 1984 Dec; 133(6):2940-9. PubMed ID: 6149245
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A novel differentiation antigen on proliferating murine thymocytes identified by a rat monoclonal antibody.
    Takei F
    J Immunol; 1984 Feb; 132(2):766-71. PubMed ID: 6418809
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treatment of a murine B cell lymphoma with monoclonal antibodies and IL 2.
    Berinstein N; Levy R
    J Immunol; 1987 Aug; 139(3):971-6. PubMed ID: 3496394
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Thy-1+ epidermal cells proliferate in response to concanavalin A and interleukin 2.
    Nixon-Fulton JL; Bergstresser PR; Tigelaar RE
    J Immunol; 1986 Apr; 136(8):2776-86. PubMed ID: 2870120
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Characterization of Thy-1 with monoclonal antibodies and evidence of Thy-3.
    Naquet P; Barbet J; Pont S; Marchetto S; Barad M; Devaux C; Rougon G; Pierres M
    Immunol Ser; 1989; 45():99-117. PubMed ID: 2577332
    [No Abstract]   [Full Text] [Related]  

  • 36. Immunosuppression with monoclonal antibodies. A model to determine the rules for effective serotherapy.
    Cobbold SP; Thierfelder S; Waldmann H
    Mol Biol Med; 1983 Oct; 1(3):285-304. PubMed ID: 6209527
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Specific destruction of allogeneic tumor cells in vivo by a bismuth-212 immunotoxin.
    Stuart FP; Perdrizet G; Steranka B; Buckingham M; Lopes D; Alvarez V; Rodwell J; McKearn T; Hines J; Atcher R
    Transplant Proc; 1987 Feb; 19(1 Pt 1):605-6. PubMed ID: 3274825
    [No Abstract]   [Full Text] [Related]  

  • 38. Administration of monoclonal anti-T cell antibodies retards murine lupus in BXSB mice.
    Wofsy D
    J Immunol; 1986 Jun; 136(12):4554-60. PubMed ID: 3086436
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Treatment of lymphoma with radiolabeled antibody: elimination of tumor cells lacking target antigen.
    Nourigat C; Badger CC; Bernstein ID
    J Natl Cancer Inst; 1990 Jan; 82(1):47-50. PubMed ID: 1967149
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In vivo immunosuppression by pan-T cell antibodies relates to their isotype and to their C1q uptake.
    Kummer U; Thierfelder S; Hoffmann-Fezer G; Schuh R
    J Immunol; 1987 Jun; 138(12):4069-74. PubMed ID: 2884259
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.